We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

LumiraDx

LumiraDx develops, manufactures and commercializes industry-leading point of care (POC) diagnostic platforms that use... read more Featured Products: More products

Download Mobile App





2021 AACC Annual Scientific Meeting & Clinical Lab Expo to Offer Free Onsite COVID-19 Testing

By LabMedica International staff writers
Posted on 09 Sep 2021
Print article
Illustration
Illustration
In its ongoing efforts to make the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo safe and healthy, the American Association for Clinical Chemistry (AACC; Washington, DC, USA), in association with LumiraDx (London, UK), will offer free onsite COVID-19 testing to all in-person attendees.

This year's AACC Annual Scientific Meeting, held in partnership with the Canadian Society of Clinical Chemists, will be a live event and has moved from Anaheim to Atlanta due to stringent COVID-19 lockdown requirements in California, with the meeting dates also being moved by one week to September 26-30. The latest move to offer onsite COVID-19 testing at the in-person meeting comes on top of the event’s already robust safety protocols that require all meeting participants to be vaccinated, and all meeting participants to have received a negative PCR or antigen COVID-19 test within 72 hours of arriving at the convention center.

To make the testing requirement as convenient as possible, AACC in association with LumiraDX will provide an onsite mobile testing unit outside the convention centre main doors where all in-person attendees can obtain a free COVID-19 test on a first come, first served basis. The results will take 30 minutes from sample collection. Attendees can avoid the necessity of fitting testing into their conference schedule by securing a test before leaving for Atlanta, as long as it falls within the three-day window. Additionally, the AACC will provide the attendees with COVID-19 self-test packets while they are at the conference and also as they prepare to return home, although supplies will be limited to the first 3,000 requests.

Related Links:
American Association for Clinical Chemistry
LumiraDx


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
3α-Diol G Assay
3α-Diol G ELISA Kit

Print article
ADLM

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Pathology

view channel
Image: The study examined the influence of pre-analytical conditions on cell-free microRNA stability in blood plasma samples (Photo courtesy of 123RF)

Pre-Analytical Conditions Influence Cell-Free MicroRNA Stability in Blood Plasma Samples

Scientists worldwide are working to enhance the quality of diagnostics and prognosis for various diseases, including cancer, by analyzing different body fluids such as blood, urine, and saliva.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.